Results 251 to 260 of about 826,474 (295)
Some of the next articles are maybe not open access.

RET oncogene

Current Opinion in Genetics & Development, 1996
RET mutations have been identified as the underlying cause of two congenital diseases that predominately affect tissues of neural crest origin: the MEN 2 cancer syndromes and a proportion of cases of dominantly inherited Hirschsprung disease, a disorder of gut development.
Y F, Mak, B A, Ponder
openaire   +2 more sources

Oncogenic signaling

Current Opinion in ONCOLOGY, 1996
Cancer develops when one or more cells begin to grow uncontrollably, presumably as a result of alterations in the highly regulated processes of normal cell division. These changes may result from germline or somatic mutations in genes that control normal cell proliferation, resulting in oncogenes.
C L, Jones, M A, Kane
openaire   +2 more sources

Oncogenes and anti-oncogenes

Current Opinion in Cell Biology, 1990
The study of oncogenes offers insights into many steps in signal transduction. Rapid progress is possible because of the combination of biochemistry and genetics--unique in vertebrate cell biology--the availability of specific clones and antibodies, sequence information, dominant mutants, and biochemical assays of function.
openaire   +2 more sources

Nuclear oncogenes

Current Opinion in Cell Biology, 1991
Ample evidence has accumulated in recent years to establish that most, if not all, nuclear proto-oncogenes are in fact sequence-specific DNA-binding proteins that modulate gene expression. Their synthesis or activity is modulated by extracellular signals or by cross talk between different classes of transcription factors.
J, Ghysdael, M, Yaniv
openaire   +2 more sources

Transient oncogenes

Medical Hypotheses, 2010
A given cancer is produced by a unique combination of genetic alterations that target specific genes, most often leading to activation of oncogenes and inactivation of tumor suppressor genes. Traditional oncogenes, such as RasV12, are involved in maintaining pro-survival and proliferation signals activated in the cell.
openaire   +2 more sources

Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment

Nature Reviews Drug Discovery, 2022
Giulia Petroni   +2 more
exaly  

Oncogenes

Current Opinion in Cell Biology, 1989
I S, Sigal, J B, Gibbs
openaire   +2 more sources

At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC

Nature Reviews Clinical Oncology, 2023
Itziar Otano, Alvaro Conrado Ucero
exaly  

Home - About - Disclaimer - Privacy